UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Brown Miller Wealth Management LLC

Brown Miller Wealth Management LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.7% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 5,697 shares of the healthcare conglomerate’s stock after buying an additional 42 shares during the quarter. UnitedHealth Group accounts for approximately 1.5% of Brown Miller Wealth Management LLC’s portfolio, making the stock its 14th biggest position. Brown Miller Wealth Management LLC’s holdings in UnitedHealth Group were worth $3,000,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in UNH. Kraft Davis & Associates LLC lifted its stake in UnitedHealth Group by 3.4% in the third quarter. Kraft Davis & Associates LLC now owns 577 shares of the healthcare conglomerate’s stock valued at $294,000 after buying an additional 19 shares during the last quarter. Iron Horse Wealth Management LLC lifted its stake in UnitedHealth Group by 1.6% in the third quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock valued at $614,000 after buying an additional 19 shares during the last quarter. Secure Asset Management LLC lifted its stake in UnitedHealth Group by 0.8% in the third quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock valued at $1,238,000 after buying an additional 19 shares during the last quarter. Bensler LLC increased its holdings in shares of UnitedHealth Group by 0.3% in the third quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock valued at $3,677,000 after purchasing an additional 19 shares during the period. Finally, Texas Capital Bancshares Inc TX increased its holdings in shares of UnitedHealth Group by 1.1% in the third quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock valued at $855,000 after purchasing an additional 19 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH stock traded up $1.60 during mid-day trading on Thursday, hitting $494.70. 3,805,551 shares of the stock traded hands, compared to its average volume of 4,097,774. UnitedHealth Group Incorporated has a twelve month low of $445.68 and a twelve month high of $554.70. The firm has a market cap of $456.08 billion, a price-to-earnings ratio of 20.70, a price-to-earnings-growth ratio of 1.34 and a beta of 0.54. The company’s 50-day simple moving average is $503.10 and its 200-day simple moving average is $518.61. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.98 by $0.18. The company had revenue of $94.43 billion for the quarter, compared to analyst estimates of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. UnitedHealth Group’s revenue for the quarter was up 14.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $5.34 earnings per share. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a yield of 1.52%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is 31.54%.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on UNH shares. Bank of America reaffirmed a “buy” rating and set a $675.00 price objective on shares of UnitedHealth Group in a report on Thursday, March 7th. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Royal Bank of Canada restated an “outperform” rating and set a $596.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 29th. Truist Financial reaffirmed a “buy” rating and set a $610.00 target price on shares of UnitedHealth Group in a report on Thursday, November 30th. Finally, HSBC reissued a “reduce” rating and issued a $480.00 price target (down previously from $550.00) on shares of UnitedHealth Group in a report on Monday, December 18th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $579.33.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.